Joel M. Wallace

Joel M. Wallace works primarily in intellectual property litigation, with significant experience in patent and trademark litigation and non-litigation analyses across a range of industries including pharmaceuticals, medical devices and consumer goods and services.
Joel Wallace

As part of his practice, Joel regularly prepares Hatch-Waxman Paragraph IV letters, advises clients on patent and regulatory issues, and advocates for clients in litigation, including fact discovery, expert discovery, trial, and appeal. Joel also has experience in post-grant review practice before the PTO, including preparation of petitions for inter partes review.

Client Work

  • Forest Laboratories, LLC v. Hikma Pharmaceuticals, LLC, 14-cv-1119 (D. Del.)
  • AstraZeneca AB v. Aurobindo Pharma Ltd., 14-cv-664 (D. Del.)
  • AztraZeneca AB v. Lupin Ltd., 11-cv-2317 (D.N.J.)
  • Allergan, Inc. v. Akorn, Inc., 14-cv-1034 (M.D.N.C.)
  • HomeVestors of America, Inc. v. Robyn Thompson, 15-cv-3616 (N.D. Tex.)
  • Antares Pharma, Inc. v. Medac Pharma Inc., 14-cv-270 (D.Del.)
  • Sanofi v. Alkem Laboratories, Ltd., 14-cv-292 (D.Del.)
  • Janssen Pharmaceuticals, Inc. v. Actavis Elizabeth LLC, 13-cv-4507 (D.N.J.)
  • Pfizer Inc. v. Fresenius Kabi USA, LLC, 13-cv-1893 (D.Del.)
  • Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC, 14-cv-4989 (D.N.J.)

Joel also participated in the following patent litigation matters prior to joining ArentFox Schiff:

  • In re Fenofibrate Patent Litigation, 11-md-2241 (S.D.N.Y.)
  • King Pharmaceuticals, Int. v. Teva Parenteral Medicines Inc., 09-cv-0652 (D.Del.)
  • Janssen Pharmaceuticals, Inc. v. Sun Global Pharma FZE, 11-cv-6089 (D.N.J.)
  • Shire Canada Inc. v. Alkem Laboratories, LLC, 11-cv-0206 (N.D.Ill.)
  • In re Nebivolol Patent (‘040) Litigation, 12-cv-5026 (N.D.Ill.)
  • Merck & Co., Inc. v. Sun Pharmaceutical Industries, Ltd., 12-cv-5374 (D.N.J.)
  • Avanir Pharmaceuticals, Inc. v. Actavis South Atlantic LLC, 11-cv-704 (D.Del.)
  • Endo Pharmaceuticals Inc. v. Watson Laboratories, Inc., 2:13-cv-192 (E.D.Tex.)
  • Antares Pharma, Inc. v. Medac Pharma, Inc., 14-cv-270 (D.Del.)
  • LoggerHead Tools, LLC v. Sears Holding Corp., 1:12-cv-9033 (N.D.Ill.)

Previous Work

Prior to joining ArentFox Schiff, Joel was an associate in the Chicago office of an international law firm.

Professional Activities

Joel represented plaintiffs in a putative class action suit regarding the issuance of immigration detainers against foreign-born U.S. citizens or legal permanent residents without investigation.

Publications, Presentations & Recognitions


  • “Rambus v. F.T.C. in the Context of Standard-Setting Organizations, Antitrust, and the Patent Hold-Up Problem,” Berkeley Technology Law Journal (2009)
  • “Surfacing from the Depths: Submarine Issues in Copyright and Rights of Publicity Licensing,” in Understanding the Intellectual Property License 2008, Practising Law Institute (2008)


  • Rising Star, Managing Intellectual Property (2021)


The Legal 500 – The Clients Guide to Law Firms